About | Free Trial

Last Update

2016-08-21T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Christopher Ariyan?

Mr. Christopher Ariyan S.

Executive Director

Remedy Inc

HQ Phone: (203) 737-5356

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Remedy Inc

333 Cedar Street TMP 400

New Haven, Connecticut 06520

United States

Company Description

In 2010 and 2011, Remedy partnered with the CerviCusco clinic in Cusco, Peru, to help perform pap smears to screen women for cervical cancer. Cervical cancer is one of the leading causes of death for women in Peru, but the disease is preventable with prop ... more

Find other employees at this company (1,797)

Background Information

Employment History

Senior Director

Pfizer Inc

Co-Founder and Executive Vice President

HealthInfo Corp

Manager

Deloitte LLP

Staff Vice President

WellPoint , Inc.

Senior Consultant

Ernst & Young LLP

Education

Yale School of Public Health

B.A.

Psychology/Pre-Med

University of Vermont

MPH

MPH degree

healthcare Management

Yale School of Management

Master of Public Health Degree

Healthcare Management

Yale University

Web References (13 Total References)


Board of Directors - REMEDY, Recovered Medical Equipment for the Developing World

remedyinc.org [cached]

Chris Ariyan, MPH, Director

Chris has 22 years of experience in the healthcare industry across the provider, payer, and pharmaceutical sectors. He is currently Senior Director, Group Leader, Specialty Access Solutions (SAS) at Pfizer's NYHQ. e began his career back in 1992 as the Executive Director of REMEDY. In 2014, Chris is now part of Pfizer's U.S. Payer Channel Access platform, where his SAS team is responsible for Pfizer's full portfolio of Specialty Pharmacy interactions as well as national payer access for the Oncology portfolio.


Board of Directors - REMEDY, Recovered Medical Equipment for the Developing World

www.remedyinc.org [cached]

Chris Ariyan, MPH, Director

Chris has 22 years of experience in the healthcare industry across the provider, payer, and pharmaceutical sectors. He is currently Senior Director, Group Leader, Specialty Access Solutions (SAS) at Pfizer's NYHQ. e began his career back in 1992 as the Executive Director of REMEDY. In 2014, Chris is now part of Pfizer's U.S. Payer Channel Access platform, where his SAS team is responsible for Pfizer's full portfolio of Specialty Pharmacy interactions as well as national payer access for the Oncology portfolio.


Board of Directors - REMEDY, Recovered Medical Equipment for the Developing World

remedyinc.org [cached]

Chris Ariyan, MPH, Director

Chris has 22 years of experience in the healthcare industry across the provider, payer, and pharmaceutical sectors. He is currently Senior Director, Group Leader, Specialty Access Solutions (SAS) at Pfizer's NYHQ. e began his career back in 1992 as the Executive Director of REMEDY. In 2014, Chris is now part of Pfizer's U.S. Payer Channel Access platform, where his SAS team is responsible for Pfizer's full portfolio of Specialty Pharmacy interactions as well as national payer access for the Oncology portfolio.


Board of Directors - REMEDY, Recovered Medical Equipment for the Developing World

www.remedyinc.org [cached]

Chris Ariyan, MPH, Director

Chris has 22 years of experience in the healthcare industry across the provider, payer, and pharmaceutical sectors. He is currently Senior Director, Group Leader, Specialty Access Solutions (SAS) at Pfizer's NYHQ. e began his career back in 1992 as the Executive Director of REMEDY. In 2014, Chris is now part of Pfizer's U.S. Payer Channel Access platform, where his SAS team is responsible for Pfizer's full portfolio of Specialty Pharmacy interactions as well as national payer access for the Oncology portfolio.


Chris Ariyan, ...

www.naspnet.org [cached]

Chris Ariyan, MPH Senior Director, Group Leader, Specialty Access Solutions Pfizer, Inc

Chris has 22 years of experience in the healthcare industry across the provider, payer, and pharmaceutical sectors. He is currently Senior Director, Group Leader, Specialty Access Solutions (SAS) at Pfizer, Inc. He began his career back in 1992 as the Executive Director of REMEDY, Inc., an international medical relief agency start up and still participates as a member of the Board of Directors today. Five years later, Chris joined Ernst & Young as a Senior Consultant in their Healthcare Provider Practice developing strategic solutions for medical practices and newly formed integrated delivery systems. In 2000, he branched out on his own again to form HealthInfo Corp, a streaming media start-up that provided online medical education for both providers and patients.
Chris then transitioned back into consulting and joined Deloitte as a Manager in their Payer Practice, where his MCO & PBM experience began. This consulting network eventually landed him a position at WellPoint, Inc. in 2002, where he worked for the next six years helping to build their strategic planning and project execution competencies. Chris rose to Staff Vice President in 2005, managing their Center's of Business Excellence to drive the identification and adoption of best practices across their 14 states (following the Anthem, Inc. and WellPoint, Inc. merger).
In 2008, Chris looked to round out his healthcare industry experience, this time in pharmaceuticals, and joined Pfizer, Inc. as a Senior Director in U.S. Payers and National Accounts. Chris managed a team of National Account Managers responsible for product access and performance across many different channels including Health Plans, PBMs, Specialty Pharmacy, Federal (VA & DoD), and Long-Term-Care.
In 2011, Chris brought his managed markets experience to Pfizer's Oncology business unit, as the Group Leader for Oncology Managed Markets, leading a team of Oncology National Account Managers to optimize the access and performance of Pfizer's growing Oncology portfolio.
In 2014, Chris is now part of Pfizer's U.S. Payer & Channel Access platform, where his SAS team is responsible for Pfizer's full portfolio of Specialty Pharmacy interactions as well as national payer access for the Oncology portfolio.
Chris graduated from the University of Vermont with a BA in Psychology and a pre-med concentration in 1992. He completed his MPH at Yale University with a concentration in Healthcare Management in 1997, and has called New York City home for the past 7 years.

Similar Profiles

Other People with this Name

Other people with the name Ariyan

Stephan Ariyan
Olam International Limited

Pouya Ariyan
Clarion Events Ltd

Arun Ariyan
Oracle Corporation

Stephan Ariyan
American Society of Maxillofacial Surgeons

Parisa Ariyan
Harrow on the Hill Dental & Implant Centre

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory